Analysis of Suffix Use for Biosimilar Product Identification in Postmarketing Adverse Event Reporting.

Inflectra (infliximab-dyyb) - Alvogen, Celltrion, Mundipharma, Egis, Nippon Kayaku, Pfizer

http://www.ncbi.nlm.nih.gov/pubmed/42702718

Danijela Stojanovic; Lisa Wolf; M Stacey Ricci; Monica A Muñoz

Sep 8, 2026